Table 3. Comparison of signal loss and noise between novel telemonitoring system using a single-lead ECG patch and the conventional telemonitoring system.
Variables | Novel telemonitoring system* | Conventional telemonitoring system† | p value for difference |
---|---|---|---|
Proportion of noise data‡ (%) | 0.3 (0.1–1.6) | 2.4 (1.4–3.7) | <0.001 |
Episodes of signal loss§ (N) | 22 (2–53) | 64 (22–112) | 0.002 |
Minimum duration of signal loss (sec) | 0.5 (0.5–0.6) | 0.5 (0.5–0.6) | 0.325 |
Maximum duration of signal loss (sec) | 4.5 (2.5–5.1) | 4.5 (4.1–4.9) | 0.064 |
Data are presented as median (interquartile range).
*ThynC™, Seers Technology, Seongnam, Korea.
†IntelliVue MX40 Patient Wearable Monitor, Philips, New York, NY, USA.
‡Most noise data were due to signal noise from motion artifacts or poor contact between electrodes and skin. The noise data excluded the episodes with signal loss.
§Most episodes of signal loss were due to transient loss of wireless connection due to participants wandering outside the effective range of the AP.
AP = access point; ECG = electrocardiogram.